204 related articles for article (PubMed ID: 28509613)
1. Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.
Middendorff G; Elsey R; Lounsbery B; Chadwell R
J Oncol Pharm Pract; 2018 Jul; 24(5):371-378. PubMed ID: 28509613
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
3. Impact of an integrated oral chemotherapy program on patient adherence.
Morgan KP; Muluneh B; Deal AM; Amerine LB
J Oncol Pharm Pract; 2018 Jul; 24(5):332-336. PubMed ID: 28379068
[TBL] [Abstract][Full Text] [Related]
4. Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.
Tschida S; Aslam S; Khan TT; Sahli B; Shrank WH; Lal LS
J Manag Care Pharm; 2013; 19(1):26-41. PubMed ID: 23383705
[TBL] [Abstract][Full Text] [Related]
5. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
[No Abstract] [Full Text] [Related]
6. Impact of Employer-Sponsored Onsite Pharmacy and Condition Management Programs on Medication Adherence.
Aguilar KM; Hou Q; Miller RM
J Manag Care Spec Pharm; 2015 Aug; 21(8):670-7. PubMed ID: 26233539
[TBL] [Abstract][Full Text] [Related]
7. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
8. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.
Pittman DG; Chen W; Bowlin SJ; Foody JM
Am J Cardiol; 2011 Jun; 107(11):1662-6. PubMed ID: 21439533
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
Bidwal M; Lor K; Yu J; Ip E
Res Social Adm Pharm; 2017; 13(4):759-766. PubMed ID: 27595427
[TBL] [Abstract][Full Text] [Related]
11. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
12. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.
Darkow T; Henk HJ; Thomas SK; Feng W; Baladi JF; Goldberg GA; Hatfield A; Cortes J
Pharmacoeconomics; 2007; 25(6):481-96. PubMed ID: 17523753
[TBL] [Abstract][Full Text] [Related]
13. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
14. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
15. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
17. Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist.
Banks AM; Peter ME; Holder GM; Jolly JA; Markley BM; Zuckerman SL; Choi L; Nwosu S; Zuckerman AD
J Pharm Pract; 2020 Oct; 33(5):605-611. PubMed ID: 30700202
[TBL] [Abstract][Full Text] [Related]
18. Specialty pharmacy for hematologic malignancies.
Fajardo S; Zook F; Dotson E
Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
[TBL] [Abstract][Full Text] [Related]
19. Development of a process to improve medication adherence in patients with rheumatoid arthritis in the specialty pharmacy setting.
Amado AY; Frye C; Holland W; Holland CR; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2020; 60(3S):S61-S64.e1. PubMed ID: 32446651
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacy services on cystic fibrosis medication adherence.
Zobell JT; Schwab E; Collingridge DS; Ball C; Nohavec R; Asfour F
Pediatr Pulmonol; 2017 Aug; 52(8):1006-1012. PubMed ID: 28608652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
